Skip to main content

Publications

Our 50 latest publications

[1]

J. Garousi et al., "Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours," European journal of pharmaceutics and biopharmaceutics, vol. 134, pp. 37-48, 2019.

[2]

D. Just, "On the profiling of autoantibodies in psychiatric disorders," Doctoral thesis Stockholm : KTH Royal Institute of Technology, TRITA-CBH-FOU, 2019:3, 2019.

[3]

M. Lundqvist et al., "Chromophore pre-maturation for improved speed and sensitivity of split-GFP monitoring of protein secretion," Scientific Reports, vol. 9, 2019.

[4]

P. E. Khoonsari et al., "Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers," Journal of Alzheimer's Disease, vol. 67, no. 2, pp. 639-651, 2019.

[5]

I. Banerjee, "Point of care microfluidic tool development for resource limited settings," Doctoral thesis Stockholm : KTH Royal Institute of Technology, TRITA-CBH-FOU, 2019:15, 2019.

[6]

S. Nybond et al., "Adenoviral detection by recombinase polymerase amplification and vertical flow paper microarray.," Analytical and Bioanalytical Chemistry, vol. 411, no. 4, pp. 813-822, 2019.

[7]

K. Subramanian et al., "Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival," Nature Microbiology, vol. 4, no. 1, pp. 62-70, 2019.

[8]

D. Wang et al., "A colorimetric assay to rapidly determine the activities of lytic polysaccharide monooxygenases," Biotechnology for Biofuels, vol. 11, no. 215, 2018.

[9]

A. Kazemzadeh et al., "A micro-dispenser for long-term storage and controlled release of liquids," Nature Communications, vol. 10, no. 1, 2019.

[10]

M. Janasch et al., "Kinetic modeling of the Calvin cycle identifies flux control and stable metabolomes in Synechocystis carbon fixation," Journal of Experimental Botany, vol. 70, no. 3, pp. 973-983, 2019.

[11]

M. Ahmed et al., "Molecular Imaging of a New Multimodal Microbubble for Adhesion Molecule Targeting," Cellular and Molecular Bioengineering, vol. 12, no. 1, pp. 15-32, 2019.

[12]

H. Idborg et al., "Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjogren's syndrome differ in molecular signatures and treatment perspectives," Arthritis Research & Therapy, vol. 21, 2019.

[13]

S. Meister, N. Hendrikse and J. Löfblom, "Directed evolution of the 3C protease from coxsackievirus using a novel fluorescence-assisted intracellular method," Biological chemistry (Print), vol. 400, no. 3, pp. 405-415, 2019.

[14]

L. Nilebäck, "Expanded knowledge on silk assembly for development of bioactive silk coatings," Doctoral thesis : KTH Royal Institute of Technology, TRITA-CBH-FOU, 2019:9, 2019.

[15]

G. Svedberg, "Novel planar and particle-based microarrays for point-of-care diagnostics," Doctoral thesis Stockholm : KTH Royal Institute of Technology, TRITA-CBH-FOU, 2019:13, 2019.

[16]

S. S. Rinne et al., "Optimization of HER3 expression imaging using affibody molecules : Influence of chelator for labeling with indium-111," Scientific Reports, vol. 9, 2019.

[17]

A. Ibrahim et al., "Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity," International Journal of Cancer, vol. 144, no. 12, pp. 3086-3098, 2019.

[18]

S. Deyev et al., "Comparative Evaluation of Two DARPin Variants : Effect of Affinity, Size, and Label on Tumor Targeting Properties," Molecular Pharmaceutics, vol. 16, no. 3, pp. 995-1008, 2019.

[19]

C. Dahlsson Leitao et al., "Molecular Design of HER3-Targeting Affibody Molecules : Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of 68 Ga-Labeled Tracers," International Journal of Molecular Sciences, vol. 20, no. 5, 2019.

[20]

M. Gonzalez-Granillo et al., "Sex-specific lipid molecular signatures in obesity-associated metabolic dysfunctions revealed by lipidomic characterization in ob/ob mouse," Biology of Sex Differences, vol. 10, 2019.

[21]

S. Hober, S. Lindbo and J. Nilvebrant, "Bispecific applications of non-immunoglobulin scaffold binders," Methods, vol. 154, pp. 143-152, 2019.

[22]

J. Steen et al., "Recognition of Amino Acid Motifs, Rather Than Specific Proteins, by Human Plasma Cell-Derived Monoclonal Antibodies to Posttranslationally Modified Proteins in Rheumatoid Arthritis," Arthritis & Rheumatology, vol. 71, no. 2, pp. 196-209, 2019.

[23]

L. C. Hjelm et al., "Lysis of Staphylococcal Cells by Modular Lysin Domains Linked via a n-covalent Barnase-Barstar Interaction Bridge," Frontiers in Microbiology, vol. 10, 2019.

[24]

R. Benfeitas et al., "Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis," EBioMedicine, 2019.

[25]

M. Neiman et al., "Individual and stable autoantibody repertoires in healthy individuals," Autoimmunity, vol. 52, no. 1, pp. 1-11, 2019.

[26]

K. Drobin et al., "Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk Loci," Inflammatory Bowel Diseases, vol. 25, no. 2, pp. 306-316, 2019.

[27]

A. Boutajangout et al., "Affibody-Mediated Sequestration of Amyloid beta Demonstrates Preventive Efficacy in a Transgenic Alzheimer's Disease Mouse Model," Frontiers in Aging Neuroscience, vol. 11, 2019.

[28]

K. G. Andersson et al., "Autotransporter-Mediated Display of a Naive Affibody Library on the Outer Membrane of Escherichia coli," Biotechnology Journal, vol. 14, no. 4, 2019.

[29]

I. Cengic, "Synthetic biology approaches for improving production of fatty acid-derived compounds in cyanobacteria," Doctoral thesis Stockholm : KTH Royal Institute of Technology, TRITA-CBH-FOU, 2019:16, 2019.

[30]

B. Turanli et al., "Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning," EBioMedicine, vol. 42, pp. 386-396, 2019.

[31]

Z. Liu et al., "Pyruvate kinase L/R is a regulator of lipid metabolism and mitochondrial function," Metabolic engineering, 2019.

[32]

K. Westerlund et al., "Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargeting," Biomaterials, vol. 203, pp. 73-85, 2019.

[33]

G. Wang et al., "RNAi expression tuning, microfluidic screening, and genome recombineering for improved protein production in Saccharomyces cerevisiae," Proceedings of the National Academy of Sciences of the United States of America, vol. 116, no. 19, pp. 9324-9332, 2019.

[34]

A. Vorobyeva et al., "Comparison of tumor-targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2," International Journal of Oncology, vol. 54, no. 4, pp. 1209-1220, 2019.

[35]

M. Mikus et al., "The antimicrobial protein S100A12 identified as a potential autoantigen in a subgroup of atopic dermatitis patients," Clinical and Translational Allergy, vol. 9, no. 1, 2019.

[36]

K. Langer and H. Jönsson, "Rapid production and recovery of cell spheroids by automated droplet microfluidics," bioRxiv, 2019.

[37]

U. Johansson et al., "Assembly of functionalized silk together with cells to obtain proliferative 3D cultures integrated in a network of ECM-like microfibers.," Scientific Reports, vol. 9, no. 1, 2019.

[38]

S. Papiol et al., "HIGH-THROUGHPUT ANTIBODY-BASED PROFILING OF SERUM IN SCHIZOPHRENIA AND BIPOLAR DISORDER PATIENTS : AN INTEGRATIVE GENOMICS-PROTEOMICS PILOT STUDY," European Neuropsychopharmacology, vol. 29, pp. S993-S994, 2019.

[39]

M. Klemencic et al., "Phylogenetic distribution and diversity of bacterial pseudo-orthocaspases underline their putative role in photosynthesis," Frontiers in Plant Science, vol. 10, 2019.

[40]

I. Banerjee et al., "Microfluidic centrifugation assisted precipitation based DNA quantification," Lab on a Chip, vol. 19, no. 9, pp. 1657-1664, 2019.

[41]

L. Lourido et al., "ITIH1 (INTER-ALPHA TRYPSIN INHIBITOR HEAVY CHAIN 1) IS A POTENTIAL PROTEOMIC BIOMARKER TO PREDICT EARLY KNEE OSTEOARTHRITIS. A QUALIFICATION PHASE STUDY USING DATA FROM THE OSTEOARTHRITIS INICIATIVE (OAI)," Osteoarthritis and Cartilage, vol. 27, pp. S69-S70, 2019.

[42]

A. Häggmark et al., "A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection," Molecular & Cellular Proteomics, vol. 18, no. 3, pp. 461-476, 2019.

[43]

M. Pernemalm et al., "In-depth human plasma proteome analysis captures tissue proteins and transfer of protein variants across the placenta," eLIFE, vol. 8, 2019.

[44]

F. J. Hu et al., "SAMURAI (Solid-phase Assisted Mutagenesis by Uracil Restriction for Accurate Integration) for antibody affinity maturation and paratope mapping," Nucleic Acids Research, vol. 47, no. 6, 2019.

[45]

H. Idborg et al., "Circulating Levels of Interferon Regulatory Factor-5 Associates With Subgroups of Systemic Lupus Erythematosus Patients," Frontiers in Immunology, vol. 10, 2019.

[46]

M. Ahmed et al., "Human serum albumin-based probes for molecular targeting of macrophage scavenger receptors," International Journal of Nanomedicine, vol. 14, pp. 3723-3741, 2019.

[47]

C. Fredolini et al., "Systematic assessment of antibody selectivity in plasma based on a resource of enrichment profiles," Scientific Reports, vol. 9, 2019.

[48]

A. Andersson et al., "Development of parallel reaction monitoring assays for cerebrospinal fluid proteins associated with Alzheimer's disease," Clinica Chimica Acta, vol. 494, pp. 79-93, 2019.

[49]

M. Mikus et al., "Asthma Sub-Phenotyping in Plasma from U-BIOPRED and BIOAIR Using Array-Based Proteomics," American Journal of Respiratory and Critical Care Medicine, vol. 199, 2019.

[50]

S. Yu et al., "An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation," PLoS ONE, vol. 14, no. 5, 2019.